Vaccine Equity

US Opts Out: Global Pandemic Treaty Agreed

After years of negotiations, nations have reached a landmark agreement on a global pandemic accord, outlining measures for prevention, preparedness, and response. A key element is a pathogen access and benefit-sharing system designed to ensure more equitable distribution of vaccines, drugs, and diagnostics during future outbreaks, addressing inequities seen during the COVID-19 pandemic. While the details remain to be finalized, the treaty mandates the timely sharing of information and requires manufacturers to provide a minimum percentage of their products to the WHO. The agreement’s adoption and ratification by member states are the next crucial steps.

Read More

$590M for Bird Flu mRNA Vaccine: A Race Against Time Amidst Healthcare Crisis Fears

The Department of Health and Human Services (HHS) recently awarded Moderna a substantial $590 million grant to accelerate the development of an mRNA vaccine against avian influenza, specifically the H5N1 strain. This significant investment underscores the growing concern surrounding the potential for a widespread bird flu outbreak.

The high mortality rate associated with H5N1, particularly among elderly individuals and young children, is a major cause for alarm. Estimates suggest a mortality rate nearing 50% in these vulnerable populations, raising the specter of a severely strained healthcare system, especially considering the lingering effects of the COVID-19 pandemic on already overburdened hospitals, particularly in rural areas.… Continue reading

WHO Launches Global Health Initiative Amidst US Withdrawal and Rising Threats

Launched on January 19, 2025, the WHO’s “Health Shield 2030” initiative aims to bolster global health security through early pandemic detection, expanded healthcare access, and climate change adaptation strategies. The initiative, supported by over 100 countries and numerous organizations, prioritizes strengthening laboratory capacities, digital health records, and equitable vaccine distribution, particularly in low- and middle-income countries. Success hinges on sustained global collaboration, funding, and political commitment to overcome implementation challenges across diverse healthcare systems. Annual progress reports, beginning in 2026, will track the initiative’s advancement.

Read More